Search

Your search keyword '"Bayer AG -- Forecasts and trends -- Growth"' showing total 234 results

Search Constraints

Start Over You searched for: Descriptor "Bayer AG -- Forecasts and trends -- Growth" Remove constraint Descriptor: "Bayer AG -- Forecasts and trends -- Growth"
234 results on '"Bayer AG -- Forecasts and trends -- Growth"'

Search Results

1. Gastrointestinal Stromal Tumor Market Expected to Experience Major Growth by 2032, According to DelveInsight | Novartis, Cogent Biosciences, Plexxikon, Ariad Pharma, Exelixis, Theseus

2. Addison's Disease Therapeutics Market to Grow by USD 442.4 Million (2024-2028) as Special Drug Designations Drive Growth, with AI Redefining the Market Landscape - Technavio

3. Deep Vein Thrombosis Market Statistics Expected to Experience Major Growth by 2032, According to DelveInsight | Bayer, LEO Pharma, Agen Biomedical, MinaPharm Pharma, GlaxoSmithKline, Pfizer

4. Companion Diagnostics Market size is set to grow by USD 28.98 billion from 2024-2028, Rising use of personalized medicine to boost the market growth, Technavio

5. Liver Cancer Drugs Market size is set to grow by USD 3.28 billion from 2024-2028, Increasing incidence of liver cancer to boost the market growth, Technavio

6. Neurostimulation Devices Market size is set to grow by USD 6.26 billion from 2023-2027, Rising prevalence of neurological disorders to boost the market growth, Technavio

7. Sciatica Treatment Market size is set to grow by USD 3.08 billion from 2023-2027, Rising awareness about sciatica to boost the market growth, Technavio

8. Anti-Inflammatory Therapeutics Market size is set to grow by USD 38.7 billion from 2024-2028, Increase in off-label use to boost the market growth, Technavio

9. Gastroesophageal Reflux Disease (GERD) Market size is set to grow by USD 879.8 million from 2024-2028, Rising geriatric population to boost the market growth, Technavio

10. Anti-Inflammatory Therapeutics Market size is set to grow by USD 38.7 billion from 2024-2028, Increase in off-label use to boost the market growth, Technavio

11. Inflammatory Bowel Disease Market size is set to grow by USD 7.61 billion from 2024-2028, Increasing incidence of ibd worldwide to boost the market growth, Technavio

12. Endocrinology Drugs Market size is set to grow by USD 36.83 billion from 2024-2028, increase in incidence of endocrine disorders to boost the market growth

13. Atopic Dermatitis Drugs Market size is set to grow by USD 6.20 billion from 2024-2028, high prevalence of atopic dermatitis to boost the market growth, Technavio

14. Endocrinology Drugs Market size is set to grow by USD 36.83 billion from 2024-2028, increase in incidence of endocrine disorders to boost the market growth, Technavio

15. Obstructive Sleep Apnea Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Apnimed, Taisho Pharma, Takeda, Bayer, Eli Lilly and Company, Axsome

16. Post-Bariatric Hypoglycemia Market Poised for Growth by 2032, Projects DelveInsight | XOMA, Zealand Pharma A/S, Eiger BioPharmaceuticals, Xeris Pharmaceuticals, Bayer, Emcure Pharmaceuticals, Virtus

17. Glaucoma Market to Observe Impressive Growth During the Forecast Period (2024-2034), Evaluates DelveInsight | Bayer, SPARC, Laboratories Sophia, Santen Pharmaceutical, Nicox Ophthalmics, Ocuphire

18. Biliary Tract Cancer Market to witness growth by 2034, estimates DelveInsight | Incyte Corporation, Loxo Oncology, Bayer, Roche, Genentech, QED Therapeutics, Agios Pharmaceuticals, Servier Pharma

19. Diabetic Kidney Disease Market to witness growth by 2034, estimates DelveInsight | Daiichi Sankyo, Prokidney, Astrazeneca, Palatin, Teijin Pharma, Chugai Pharmaceutical, Bayer, Chinook Therapeutics

20. Neuropathic Pain Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | WEX Pharmaceuticals Inc., Lexicon Pharmaceuticals Inc., Bayer

21. Nuclear Medicine Market to Increase by USD 8.06 Billion, Analyzing Growth Opportunities in Radiotherapeutics Segment - Technavio

22. Hospital Infection Therapeutics Market is to grow by USD 3.10 billion, Special drug designations to boost growth - Technavio

23. Congestive Heart Failure Market: Latest Study by DelveInsight Forecasts Remarkable Growth During the Forecast Period (2023-32) | Otsuka, Eli Lilly, AstraZeneca, Mesoblast, Bayer, Novo Nordisk

24. Over The Counter (OTC) Analgesics Market to grow by USD 6.52 billion from 2022 to 2027, North America accounts for 42% of market growth- Technavio

25. Insights on the Cough Syrup Global Market to 2027 - Increasing Prevalence of Upper Respiratory Tract Infection and Other Respiratory Disorders Drives Growth - ResearchAndMarkets.com

26. Erectile Dysfunction (ED) Drugs Market to grow by USD 1.44 billion from 2023-2028, North America to account for 41% of market growth - Technavio

27. Companion animal specialty drugs market to grow by USD 4.55 billion from 2023 to 2028; North America to account for 35% of market growth- Technavio

28. Acute Ischemic Stroke Market Set to Experience Unprecedented Growth During the Forecast Period (2023-32) - Estimates DelveInsight | AbbVie, Acticor, Athersys, Healios, Bayer, Clinuvel, NuvOx

29. Erdheim-Chester disease (ECD) Market to Witness Growth by 2032, Estimates DelveInsight | Companies - Johnson & Johnson, Mylan N.V., Sun Pharmaceutical, Sanofi, Bayer, Lilly, GSK, Novartis

30. Coagulation Factor Deficiency Market to Witness Growth by 2032, Estimates DelveInsight | Companies - Pfizer, Grifols, Biogen, Octapharma, Baxter, Bayer

31. Ischemic Stroke Market to Witness Growth by 2032, Estimates DelveInsight | Companies - Boehringer Ingelheim Pharmaceuticals, Inc., Bayer AG, Bristol-Myers Squibb Company, Pfizer Inc., AstraZeneca

32. Neurostimulation Devices Market to grow by USD 6.25 billion from 2022 to 2027, North America to account for 40% of market growth - Technavio

33. Kidney Diseases Market Set for Remarkable Growth with 7.5% CAGR, Reaching $128.15 Billion by 2027: Leading Players Pfizer, Johnson & Johnson, Roche Driving Advances in Kidney Disease Treatments

34. Scleroderma Market Set to Experience Unprecedented Growth During the Forecast Period (2023-32) - DelveInsight | Biocad, Kyowa Kirin, Bayer, Maruho, Certa Therapeutics, Emerald Health, Acceleron

35. Diabetic Retinopathy Market to Register Incremental Growth by 2032, Asserts DelveInsight | Leading Companies in the Market - Opthea, Regenxbio, Kodiak, Ocuphire, Eisai, Apexian, Oculis, Bayer, Novartis, Allegro

36. HER2+ Gastric Cancer Market Anticipating Remarkable Growth by 2032, Insights by DelveInsight | Bayer, BMS, Loxo Oncology, Merus, Daiichi Sankyo, LintonPharm, Eli Lilly, Genentech, Innovent, Remegen

37. Antibacterial Drugs Market to grow by USD 9.90 billion from 2022 to 2027 | Asia to account for 42% of market growth- Technavio

38. Radiopharmaceuticals Market size to grow by USD 4.61 billion from 2022 to 2027, North America to account for 42% of market growth - Technavio

39. Congestive Heart Failure Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies - Otsuka Pharmaceuticals, AstraZeneca, Applied Therapeutics, Bayer, Novo No

40. Diabetic Kidney Disease Market is Expected to Expand at a Healthy Growth Rate During the Study Period (2019 -2032)|Key Companies - Bayer, Pfizer

41. Osteosarcoma Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Bayer, MedPacto, Zentalis Pharmaceuticals, Hutchmed, AstraZeneca, Pfizer

42. High Grade Glioma Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies - Basilea Pharmaceuticals, Bayer, BioMimetix, Diffusion Pharmaceuticals

43. Idiopathic Interstitial Pneumonias Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies - Bayer, Reata Pharmaceuticals

44. Germ Cell Tumor Market to witness growth by 2032, estimates DelveInsight | Takeda Pharmaceutical Company Limited, Novartis, Bristol Myers Squibb, Merck, Roche, Bayer

45. Glioblastoma Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies Bayer, Chimerix, Aivita Biomedical

46. Endocrinology drugs market to grow by USD 36.55 billion from 2022 to 2027, North America to account for 45% of market growth- Technavio

47. Tonsillitis Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies - Sanofi, Pfizer, Bayer

48. Major Players Merck & Co, Roche, and Pfizer Fuel Growth of Global 5-Alpha Reductase Deficiency Market to 2032

49. Global Plantar Fasciitis Treatment Market to Witness Remarkable Growth, Projected to Reach $3 Billion by 2027

50. Major Players Abbott, Pfizer, and Novartis Drive Growth in Global Hormone Therapy Market to 2032

Catalog

Books, media, physical & digital resources